1. Home
  2. KOSS vs IPSC Comparison

KOSS vs IPSC Comparison

Compare KOSS & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koss Corporation

KOSS

Koss Corporation

HOLD

Current Price

$4.85

Market Cap

43.6M

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$0.53

Market Cap

47.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOSS
IPSC
Founded
1953
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.6M
47.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KOSS
IPSC
Price
$4.85
$0.53
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.00
AVG Volume (30 Days)
25.6K
1.0M
Earning Date
10-30-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,493,080.00
$113,337,000.00
Revenue This Year
N/A
$1,589.94
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.58
4122.69
52 Week Low
$4.00
$0.34
52 Week High
$8.59
$1.74

Technical Indicators

Market Signals
Indicator
KOSS
IPSC
Relative Strength Index (RSI) 51.05 48.16
Support Level $4.81 $0.50
Resistance Level $4.99 $0.56
Average True Range (ATR) 0.19 0.04
MACD 0.04 0.00
Stochastic Oscillator 71.43 72.54

Price Performance

Historical Comparison
KOSS
IPSC

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: